1,750,000 KRW
40
2.23%
Last update Dec 17, 3:00 PM KST
Main market
Day range
1,740,000
1,790,000
Previous close
1,790,000
Open
1,790,000
Access this stock data via API
Subscribe
Samsung Biologics Co., Ltd.
1,750,000.00
40K
2.23%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 1.7T 1.3T 1.3T 1.3T
Cost of revenue 681.4B 570.9B 565.4B 587.7B
Gross profit 978.8B 719.0B 732.8B 668.7B
Operating expense
Research & development 34.3B 40.3B 35.3B 63.9B
Selling general and admin 110.9B 98.0B 105.3B 181.7B
Other operating expenses 4.6B 6.9B 11.8B 6.8B
Operating income 728.8B 475.6B 486.7B 325.7B
Non operating interest income
Income 13.4B 12.4B 13.2B 13.7B
Expense 10.7B 8.3B 9.9B 24.1B
Other income expense
Pretax income 767.0B 408.9B 499.4B 374.0B
Tax provision 192.5B 84.5B 123.8B 52.5B
Net income 574.5B 324.4B 375.6B 321.5B
Basic EPS 12.4K 4.6K 5.3K
Diluted EPS 12.4K 4.6K 5.3K
Basic average shares 46.3M 71.2M 71.2M
Diluted average shares 46.3M 71.2M 71.2M
EBITDA 956.7B 594.4B 673.7B 593.2B
Net income from continuing op. 574.5B 324.4B 375.6B 321.5B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 3 hours 18 minutes

12:11
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:30 - 09:00
Main market
09:00 - 15:30
Post-market
15:30 - 18:00
All times are displayed in the Asia/Seoul timezone (KST, UTC+09:00).